| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Robert Lorne Hopfner is Director at PCVX and has filed Form 4s across 3 companies. From June 2020 to October 2026, the filings on record show 3 open-market purchases and 8 sales. Robert Lorne Hopfner's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $86.9M at current prices.
The biggest single holding is PCVX (~$86.6M) as Director. The PCVX filings lean toward selling, a net 724,549 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2020 | PCVX Vaxcyte, Inc. | Director | Buy | 93,000 | $16.00 | $1,488,000.00 | +4.4% |